Literature DB >> 22660961

Population-based survival data for brain tumors in Korea.

Kyu-Won Jung1, Heon Yoo, Hyun-Joo Kong, Young-Joo Won, Sohee Park, Seung Hoon Lee.   

Abstract

Primary brain tumors are relatively uncommon but particularly lethal cancers. Although survival is useful for monitoring the effects of early cancer detection and treatment, there are few population-based estimates of survival for subjects with brain tumors, especially in Asian countries. Using the Korea National Cancer Incidence Database, 4,721 newly diagnosed cases of histologically confirmed malignant primary brain tumors from 1999 to 2004 were analyzed for observed survival. For trend analyses of glioblastomas, we included 2,751 glioblastoma cases diagnosed between 1999 and 2007. We compared survival by age group and histological type by use of the Kaplan-Meier method. For all ages and all brain tumor types in Korea, five-year survival was 37.5 %. For each histological type of brain tumor survival of pediatric and younger adult populations was much better than that of older adults. Five-year survival for glioblastoma, astrocytoma, anaplastic astrocytoma, and oligodendroglioma was 8.9, 51.6, 25.2, and 73.5 %, respectively. Two-year survival for glioblastoma increased from 18.6 % for cases diagnosed in 1999-2001 to 21.3 % for cases diagnosed in 2002-2004 and to 24.7 % for cases diagnosed in 2005-2007. These results may help clinicians and patients to assess long-term prognoses for brain tumors, and the data presented here could serve as master control data set for single-arm clinical trials, especially in Asian populations.

Entities:  

Mesh:

Year:  2012        PMID: 22660961     DOI: 10.1007/s11060-012-0893-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.

Authors:  Robert Cardinale; Minhee Won; Ali Choucair; Michael Gillin; Arnab Chakravarti; Christopher Schultz; Luis Souhami; Allan Chen; Huong Pham; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-05       Impact factor: 7.038

2.  Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.

Authors:  M Weller; T Gorlia; J G Cairncross; M J van den Bent; W Mason; K Belanger; A A Brandes; U Bogdahn; D R Macdonald; P Forsyth; A O Rossetti; D Lacombe; R-O Mirimanoff; C J Vecht; R Stupp
Journal:  Neurology       Date:  2011-08-31       Impact factor: 9.910

3.  Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.

Authors:  Amy S Darefsky; Joseph T King; Robert Dubrow
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

4.  A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

Authors:  Manfred Westphal; Dana C Hilt; Enoch Bortey; Patrick Delavault; Robert Olivares; Peter C Warnke; Ian R Whittle; Juha Jääskeläinen; Zvi Ram
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

5.  Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume.

Authors:  Jean Marc Simon; Philippe Cornu; Gilbert Boisserie; Dominique Hasboun; Bernadette Tep; Claire Hardiman; Charles A Valery; Jean Yves Delattre; Didier Dormont; François Baillet; Jean Jacques Mazeron
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-05-01       Impact factor: 7.038

6.  Epidemiology of primary brain and central nervous system tumors in Korea.

Authors:  Chang-Hyun Lee; Kyu-Won Jung; Heon Yoo; Sohee Park; Seung Hoon Lee
Journal:  J Korean Neurosurg Soc       Date:  2010-08-31

7.  Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.

Authors:  Sundeep Deorah; Charles F Lynch; Zita A Sibenaller; Timothy C Ryken
Journal:  Neurosurg Focus       Date:  2006-04-15       Impact factor: 4.047

8.  Radiosurgical boost for primary high-grade gliomas.

Authors:  Flavio E Prisco; Eduardo Weltman; Rodrigo M de Hanriot; Reynaldo A Brandt
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

9.  Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database.

Authors:  Hai-Rim Shin; Young-Joo Won; Kyu-Won Jung; Hyun-Joo Kong; Seon-Hee Yim; Jung-Kyu Lee; Hong-In Noh; Jong-Koo Lee; Paola Pisani; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

10.  Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973-1997.

Authors:  Jill S Barnholtz-Sloan; Andrew E Sloan; Ann G Schwartz
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

View more
  13 in total

Review 1.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

2.  Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions.

Authors:  Song Tao Timothy Cheo; Gek Hsiang Lim; Keith Hsiu Chin Lim
Journal:  Singapore Med J       Date:  2016-02-26       Impact factor: 1.858

3.  Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report.

Authors:  Rebecca L Achey; Vishesh Khanna; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2017-04-10       Impact factor: 4.130

4.  Automated Grading of Gliomas using Deep Learning in Digital Pathology Images: A modular approach with ensemble of convolutional neural networks.

Authors:  Mehmet Günhan Ertosun; Daniel L Rubin
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

5.  Functional Improvement After 4-Week Rehabilitation Therapy and Effects of Attention Deficit in Brain Tumor Patients: Comparison With Subacute Stroke Patients.

Authors:  Eun Young Han; Min Ho Chun; Bo Ryun Kim; Ha Jeong Kim
Journal:  Ann Rehabil Med       Date:  2015-08-25

6.  Population-based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009.

Authors:  Sang-Hoon Shin; Kyu-Won Jung; Johyun Ha; Seung Hoon Lee; Young-Joo Won; Heon Yoo
Journal:  Cancer Res Treat       Date:  2015-02-12       Impact factor: 4.679

7.  Genomic and Molecular Characterization of Brain Tumors in Asian and Non-Asian Patients of Los Angeles: A Single Institution Analysis.

Authors:  Courtney Duong; Thien Nguyen; John P Sheppard; Vera Ong; Lawrance K Chung; Daniel T Nagasawa; Isaac Yang
Journal:  Brain Tumor Res Treat       Date:  2017-10-31

8.  Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis.

Authors:  Michael T C Poon; Cathie L M Sudlow; Jonine D Figueroa; Paul M Brennan
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

9.  The Significance of Lactate and Lipid Peaks for Predicting Primary Neuroepithelial Tumor Grade with Proton MR Spectroscopy.

Authors:  Hisao Nakamura; Masatomo Doi; Takuya Suzuki; Yasuyuki Yoshida; Masahiro Hoshikawa; Masashi Uchida; Yuichiro Tanaka; Masayuki Takagi; Yasuo Nakajima
Journal:  Magn Reson Med Sci       Date:  2017-08-16       Impact factor: 2.471

10.  Intensive Rehabilitation Therapy Following Brain Tumor Surgery: A Pilot Study of Effectiveness and Long-Term Satisfaction.

Authors:  Junghoon Yu; Youngsu Jung; Joonhyun Park; Jong Moon Kim; Miri Suh; Kyung Gi Cho; MinYoung Kim
Journal:  Ann Rehabil Med       Date:  2019-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.